Gaudium IVF & Women Health
GAUDIUMIVF NSE
Gaudium IVF & Women Health
HealthcareNSE: GAUDIUMIVF BSE: 544709 Healthcare Service Provider
Key Fundamentals
MicrocapHealthcare Service ProviderHealthcareMarket Cap
₹827 Cr
Volatility
Moderate
P/E Ratio
33.55
EBITDA
₹37.71 Cr
Return on Equity
41.31%
Debt to Equity
0.16
Book Value
₹20.92
52W High
₹163.18
52W Low
₹69.18
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 187 days.
- Working capital days have increased from 39.9 days to 90.9 days
Growth Rate
Revenue Growth
46.99% higher than
3Y
Net Income Growth
28.06% higher than
3Y
Cash Flow Change
153% higher than
3Y
ROE
-17.21% lower than
3Y
ROCE
-15.64% higher than
3Y
EBITDA Margin (Avg.)
-11.61% higher than
3Y
Quarterly Results
| Particulars | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 14.42 | 26.92 | 17.76 | 31.73 | 24.51 | 30.35 | 19.38 |
| Expenses | 8.76 | 18.2 | 12.61 | 17.96 | 17.95 | 18.18 | 16.95 |
| Operating Profit | 5.66 | 8.72 | 5.15 | 13.77 | 6.56 | 12.17 | 2.43 |
| OPM % | 39.25% | 32.39% | 29% | 43.4% | 26.76% | 40.1% | 12.54% |
| Other Income | 0 | 0.23 | 0 | 0.15 | 0.1 | 0.18 | 1.12 |
| Interest | 0.39 | 0.43 | 0.5 | 0.51 | 1.2 | 1.29 | 0.38 |
| Depreciation | 0.58 | 0.36 | 0.61 | 0.61 | 0.49 | 0.64 | 0.72 |
| PBT | 4.69 | 8.16 | 4.04 | 12.8 | 4.97 | 10.42 | 2.45 |
| Tax % | 27.72% | 20.96% | 24.01% | 26.64% | 26.96% | 19.77% | 27.76% |
| Net Profit | 3.4 | 6.46 | 3.07 | 9.38 | 3.63 | 8.36 | 1.78 |
| EPS in Rs | 0.55 | 1.05 | 0.5 | 1.53 | 0.59 | 1.15 | 0.24 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 37 | 44 | 48 | 71 | 104 | 106 |
| Expenses | 23 | 24 | 28 | 42 | 67 | 71 |
| Operating Profit | 14 | 20 | 19 | 29 | 38 | 35 |
| OPM % | 37% | 46% | 41% | 41% | 36% | 33% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 2 |
| Interest | 1 | 0 | 1 | 2 | 3 | 3 |
| Depreciation | 1 | 1 | 2 | 2 | 3 | 2 |
| PBT | 12 | 18 | 17 | 25 | 32 | 31 |
| Tax % | 26% | 26% | 38% | 25% | 24% | — |
| Net Profit | 9 | 14 | 10 | 19 | 24 | 23 |
| EPS in Rs | 89.17 | 137 | 104 | 3.12 | 3.36 | 3.51 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 0.99 | 0.99 | 0.99 | 31 | 36 |
| Reserves | 8 | 22 | 26 | 16 | 116 |
| Borrowings | 6 | 12 | 17 | 21 | 25 |
| Other Liabilities | 3 | 2 | 7 | 22 | 16 |
| Total Liabilities | 18 | 37 | 51 | 89 | 193 |
| Fixed Assets | 4 | 18 | 19 | 18 | 30 |
| CWIP | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 5 |
| Other Assets | 14 | 18 | 32 | 58 | 158 |
| Total Assets | 18 | 37 | 51 | 89 | 193 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | -1 | 24 | 3 | 9 | 7 |
| Investing | -1 | -16 | -5 | -15 | -88 |
| Financing | 3 | 5 | -1 | 2 | 82 |
| Net Cash Flow | 0 | 13 | -3 | -5 | 2 |
| Free Cash Flow | -2 | 9 | 1 | 0 | 5 |
| CFO/OP | 13 | 141 | 27 | 46 | 51 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 65 | 8 | 104 | 170 | 187 |
| Inventory Days | 29 | 111 | 168 | 175 | 38 |
| Days Payable | 114 | 77 | 62 | 338 | 133 |
| Cash Conversion Cycle | -20 | 41 | 210 | 7 | 92 |
| Working Capital Days | 61 | -52 | -15 | 44 | 91 |
| ROCE % | — | 76% | 45% | 49% | 29% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Gaudium IVF & Women Health insights
45 extracted metrics + investor summaries across FY22–FY26.
Documents
1
Clarification On Price Movement
16 Apr - Company clarified price movement was market-driven and disclosed no new price-sensitive information. 16 Apr - Company clarified price movement was market-driven and disclosed no new price-sensitive information.
3
Intimation Regarding Change Of Corporate Identification Number Of The Company
15 Apr - Company CIN changed to L85100DL2015PLC278296; status updated from unlisted to listed. 15 Apr - Company CIN changed to L85100DL2015PLC278296; status updated from unlisted to listed.
4
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
10 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026; no rematerialisation requests. 10 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026; no rematerialisation requests.
5
Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) Regu
7 Apr - Bombay High Court disposed Neomile petition on April 2, 2026; Justice Nitin Jamdar appointed sole arbitrator. 7 Apr - Bombay High Court disposed Neomile petition on April 2, 2026; Justice Nitin Jamdar appointed sole arbitrator.
Frequently Asked Questions about Gaudium IVF & Women Health
What does Gaudium IVF and Women Health Ltd do?
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
Where is Gaudium IVF and Women Health Ltd (GAUDIUMIVF) listed?
Gaudium IVF and Women Health Ltd trades as GAUDIUMIVF on the NSE and under code 544709 on the BSE.
Which sector does Gaudium IVF and Women Health Ltd belong to?
Gaudium IVF and Women Health Ltd is classified under the Healthcare sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd has a market capitalisation of ₹827.15 Cr, which places it in the Small Cap band.
What is the PE ratio of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd trades at a PE ratio of 33.55, against a book value of ₹20.92 per share.
What is the 52-week high and low of Gaudium IVF and Women Health Ltd?
Over the last 52 weeks Gaudium IVF and Women Health Ltd has traded between ₹69.18 and ₹163.18.
What is the Return on Equity (ROE) of Gaudium IVF and Women Health Ltd?
Gaudium IVF and Women Health Ltd reported a return on equity of 41.31%. Its debt-to-equity ratio is 0.16.
Company Information
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GAUDIUMIVF.md for Gaudium IVF and Women Health Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.